Turner v. Lincon-Vitale

District Court, S.D. New York·Decided December 22, 2020·No. 1:20-cv-05473·Unknown

Opinion

USDC SDNY DOCUMENT SOUTHERN DISTRICT OF NEW YORK DOC #: annonces nana nna sansa nnscn KK DATE FILED:_12/22/2020 WILBERT K.A. TURNER, : Plaintiff, : : 20-cv-5473 (LJL) -v- : : ORDER M. LINCON-VITALE & WILLIAM BARR, : Defendants. :

nee ee K LEWIS J. LIMAN, United States District Judge: Plaintiff Wilbert K.A. Turner (“Plaintiff’ or “Turner”) is an inmate at the Metropolitan Correctional Center (“MCC”) in New York, New York. He brings this action seeking damages against M. Lincon-Vitale, Warden of the MCC (the “Warden”), and Attorney General William Barr (“Barr”) in their “official” capacities, alleging that the Warden failed to follow written guidance from the Federal Bureau of Prisons and the Centers for Disease Control regarding the COVID-19 pandemic. Dkt. No. 2. The United States now moves to substitute the United States of America for the Warden and Barr and to dismiss the complaint based on Plaintiffs failure to exhaust administrative remedies under the Federal Torts Claims Act (“FTCA”), 28 U.S.C. § 2671, et seq. Dkt. No. 12. THE ALLEGATIONS OF THE COMPLAINT The Court construes liberally the allegations of the pro se complaint as well as the facts stated in Turner’s opposition to the motion to dismiss, all of which the Court accepts as true for purposes of this motion. The Court eliminates reference to other inmates by their proper name for reasons of those inmates’ medical privacy.

Turner is an inmate of the MCC in New York, New York where he has been detained since April 2018. Dkt. No. 15 at 1. He is housed in a dormitory room which is shared by 25 other inmates and is required to sleep next to five inmates who are less than six feet apart from him. Id. at 2. He alleges that a fellow inmate became ill on March 27, 2020, after which he was “put in a wheelchair after sleeping for three consecutive days” and “was not seen again until

approximately thirty days later.” Dkt. No. 2 at 4. After that inmate left, several other inmates began to display symptoms of COVID-19. Id. at 4-5. Turner suffered the following symptoms: “diarrhea, drowsiness, no smell, no appetite, and los[s] of weight 20 lbs.” Id. at 5. Those symptoms caused him “mental anguish, anxiety, [and] sleepless nights.” Id. On March 30, 2020, his temperature was 104.5 degrees Fahrenheit. Id. Two hours later, his temperature was 100.1 degrees, and he was prescribed acetaminophen without explanation. Id. He complains that the Warden failed to “comply with social distancing or ma[ke] mask[s] available. Id. at 6.1 After the sick inmate returned, the MCC did not inform Plaintiff of the inmate’s condition, “the area was not disinfected per CDC guidelines,” and the inmate was “returned to population

without a negative testing.” Id. Turner “repeatedly requested testing verbally,” to no avail. Id. The Warden only provided disinfectant during weekdays and not on weekends, with the result that “on weekends the bathroom now goes unclean[ed].” Id. “Some [of the guards] wear masks some don’t.” Id. He asserts that the Warden “fails to ensure my health safety.” Id. He received a test for COVID-19 on August 3, 2020, which came back positive on August 12, 2020. Dkt. No. 15, at 3. He was quarantined, forced to sleep on a concrete slab for four days because the MCC had no other space, and experienced shortness of breath. Id.

1 In his brief in opposition to the motion to dismiss, the allegations of which are also taken as true, Turner complains that he asked to be tested and asked to be removed from the unit where he was housed, but that his requests were ignored. Dkt. No. 15 at 2. Turner alleges he has several underlying conditions including an autoimmune disease, bladder cancer, heart disease (for which he wears a defibrillator) and asthma. Dkt. No. 2 at 6. He is scheduled to be released from the MCC at the end of this month to a detainer from the United States Immigration and Customs Enforcement (“ICE”) and is not contesting his removal to Jamaica. Id.

DISCUSSION As “sovereign,” the United States is subject to suit only to the extent “it consents to be sued . . ., and the terms of its consent to be sued in any court define that court’s jurisdiction to entertain the suit.” United States v. Sherwood, 312 U.S. 584, 586 (1941). Under the FTCA, “a suit against the United States is the exclusive remedy for a suit for damages for injury or loss of property ‘resulting from the negligent or wrongful act or omission of any employee of the Government while acting within the scope of his office or employment.’” Rivera v. United States, 928 F.2d 592, 608 (2d Cir. 1991) (quoting 28 U.S.C. § 2679(b)(1)). Before a tort claim may be presented to a federal court, it must previously have been “presented to the appropriate

administrative agency.” Millares Guiraldes de Tineo v. United States, 137 F.3d 715, 719 (2d Cir. 1998). “[T]he United States has not consented to be sued on a tort claim unless the claim was first presented to the appropriate federal agency in writing, was so presented within two years after the claim accrued, and specified the amount of the claim in writing.” Id. at 720. Thus, the FTCA provides, inter alia, that: “[a]n action shall not be instituted upon a claim against the United States for money damages for injury or loss of property or personal injury or death caused by the negligent or wrongful act or omission of any employee of the Government while acting within the scope of his office or employment, unless the claimant shall have first presented the claim to the appropriate Federal agency.

28 U.S.C. § 2675(a). If the claim has not previously been presented to the appropriate federal agency, the District Court lacks subject matter jurisdiction to entertain it. Celestine v. Mount Vernon Neighborhood Health Ctr., 403 F.3d 76, 82 (2d Cir. 2005) (“The FTCA requires that a claimant exhaust all administrative remedies before filing a complaint in federal court. This requirement is jurisdictional and cannot be waived”); Millares Guraildes, 137 F.3d at 720-21 (same); Wyler

v. United States, 725 F.2d 156, 159 (2d Cir. 1983) (same); Mil’chamot v. United States, 2016 WL 10570933 (S.D.N.Y. Dec. 9, 2016) (same). “The burden is on the Plaintiff to both plead and prove compliance with the [FTCA’s] statutory requirements.” In re Agent Orange Prod. Liab. Litig., 818 F.2d 210, 214 (2d Cir. 1986); Bonifacio v. United States, 2020 WL 5801475, at *4 (S.D.N.Y. Sept. 28, 2020); Vailette v. Lindsay, 2014 WL 4101513, at *5 (E.D.N.Y. Aug. 18, 2014). “[T]his ‘procedural hurdle applies equally to litigants with counsel and to those proceeding pro se.’” Bonifacio, 2020 WL 5801475, at *4 (quoting Adeleke v. United States, 355 F.3d 144, 153 (2d Cir. 2004)). Section 2679 further provides that upon certification by the “Attorney General that the

defendant employee was acting within the scope of his office or employment,” the United States “shall be substituted as the party defendant,” 28 U.S.C. § 2679

Free access — add to your briefcase to read the full text and ask questions with AI

Turner v. Lincon-Vitale, (S.D.N.Y. 2020).

Turner v. Lincon-Vitale (Turner v. Lincon-Vitale) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related